Julie Betts Ebert is a Managing Director on the National Life Science & Healthcare team at Silicon Valley Bank, covering the Mid-Atlantic and Southeast markets.  Julie provides specialized banking services and debt-financing solutions, as well as advice on strategic growth, to life science companies across all sectors and life stages, from early-stage venture-backed enterprises to late-stage public companies. 

Before joining the commercial banking team, Julie spent several years leading SVB’s Strategic Advisory effort, where she was responsible for managing client engagements and leading execution for advisory projects.

Julie received an M.B.A. with honors from Columbia Business School and a B.S. from the McIntire School of Commerce at the University of Virginia with concentration in finance.

Ivan Oscar Asensio advises global corporations and institutional investment managers on solving problems related to currency risk. He has held similar roles at HSBC, Merrill Lynch & Co., and Bank of America in New York, San Francisco and Los Angeles. His approach when engaging clients involves the use of quantitative techniques for purposes of risk discovery, risk quantification, and ultimately the development of tailored strategies that are consistent with the institution’s stage in the life cycle, performance objectives, desired accounting presentation, and risk tolerance.

Dr. Asensio received his Ph.D. in economics from the University of California, Santa Cruz. He also holds an M.S. degree in statistics from UCLA, and dual-undergraduate degrees in finance and mathematics from USC.

Mr. Franklin has been CFO of numerous venture-backed companies including most recently serving as CFO of myoscience (therapeutics/aesthetics) for six years. He specializes in helping Pre-IPO companies get through initial commercialization. In 2000, he co-founded, CFO Connection, a financial services firm that assists technology and medtech companies in successfully building their businesses. Prior to CFO Connection he was ACLARA BioSciences’ (medtech) top financial officer for four years. Earlier in his career he was Co-Founder and CFO at BioLumin Corporation (sold to GE Healthcare) and held senior financial positions at VeloBind (Manufacturing) and Precision Echo (Defense Manufacturer), both public companies.

Mr. Franklin received a BS in Business from the University of Southern California and an MBA from Santa Clara University.

Peter Compton is a senior foreign exchange advisor for Silicon Valley Bank’s global financial services group, and has been with SVB since 2007. He helps clients design and implement hedging strategies for foreign currency exposures. Compton has over 20 years experience in global financial markets. Before joining Silicon Valley Bank, Compton spent seven years working in the European equity markets. Based in Germany, he spent four years with HSBC and three years as Head of Equity Sales for ABN-AMRO in Frankfurt. Prior to his work overseas, Compton spent seven years with Bank of America in San Francisco as an equity and fixed income derivative specialist.

Compton holds a bachelor's degree in business and management from the University of Rhode Island and a Master's of Business Administration from San Francisco State University.

Robert Judd is the VP of Finance and Accounting for Alphatec Spine (ATEC).  ATEC is a NASDAQ listed public company specializing in innovative spine surgery solutions. He’s worked at ATEC for almost 3 years and has almost 15 years of experience in Life Science / Healthcare finance having worked at NuVasive, Thermo Fisher Scientific, Life Technologies and Allergan. He began his career in public accounting at KPMG. Robert graduated cum laude with undergraduate and graduate degrees from Brigham Young University.